Company Filing History:
4 out of 113 
3 out of 4,446 
Years Active: 2012-2017
Title: Frank Song: Innovator in Modified Erythropoietin Polypeptides
Introduction
Frank Song is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of modified animal erythropoietin polypeptides. With a total of 4 patents to his name, his work has implications for various medical applications.
Latest Patents
Frank Song's latest patents focus on modified animal erythropoietin polypeptides and their uses. These innovations provide new avenues for therapeutic applications, enhancing the efficacy of treatments related to erythropoiesis.
Career Highlights
Throughout his career, Frank has worked with prominent companies such as Ambrx, Inc. and Eli Lilly and Company. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in his field.
Collaborations
Frank has collaborated with talented individuals, including Feng Tian and Anna-Maria A Hays Putnam. These partnerships have fostered a creative environment that has led to innovative solutions in biotechnology.
Conclusion
Frank Song is a distinguished inventor whose work in modified erythropoietin polypeptides showcases his commitment to advancing medical science. His contributions continue to influence the field and inspire future innovations.